Where we live and work shapes us in many ways. Whether growing up in an urban, suburban, or rural community, our neighborhoods can have an outsized impact our hobbies, lifestyle, and health. It was inspiring to see so many investigators presenting findings on this topic today at the American Heart Association (AHA) 2019 Scientific Sessions … Read more
I have always advocated making time to attend a talk that’s outside of your area of focus when attending a big conference. It’s a powerful way to experience new perspectives. On Monday, the last day of Sessions, there was a panel held in Main Event I— the grand stage, where the presidential session and the … Read more
The Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial1 has been a landmark in clinical decision-making for patients with stable ischemic heart disease – leading to a paradigm shift in clinical care by establishing that revascularization/percutaneous coronary intervention(PCI) in patients with stable ischemia did not reduce subsequent mortality or myocardial infarction(MI) outcomes over … Read more
Another successful scientific session in the books and I am already looking forward to the next one #AHA20, on to Dallas. But first, from the City of brotherly love, these are some of the highlights. Let the countdown begin. 5) Late breaking clinical trials There is usually a lot of noise around these sessions. … Read more
I have gone back and forth with attending the American Heart Association (AHA) Scientific Sessions online in 2017 (AHA17), to onsite (AHA18), and this year (AHA19) I attended online again. There was absolutely no comparison between attending AHA18 to the online versions! I was the first to say that going to conference is overwhelming because … Read more
Mechanical circulatory support (MCS) use in cardiogenic shock (CS) in the setting of acute myocardial infarction (AMI) is one of the most controversial topics in cardiology. Despite advances in many aspects in our cardiovascular field, mortality from CS remains unacceptably high. At the most recent AHA meeting, two studies suggested the use of intra-aortic balloon … Read more
I left Scientific Sessions 2019 (AHA19) feeling so refreshed, empowered, motivated, and ready to rock it when I got home to Boston. I’ve been told this a lot, but I really felt it this time – that conferences serve more than just to educate and provide a venue for networking; they rejuvenate you. We all … Read more
Public communication and knowledge dissemination are often thought of as straight cut, on/off types of action, especially in medicine and the broader health sciences. However it is also very evident in our present day that miscommunication and inaccurate knowledge sharing exists, and has increasingly harmful consequences on the global population. Examples of this are plenty, … Read more
This year’s #AHA19 meeting, despite its abbreviated 3-day format, delivered a fantastic lineup of basic science research sessions, comprising of presentations from trainees to early career and senior investigators. Here I review some of the major topics in basic science cardiovascular research highlighted at #AHA19! This is by no means a comprehensive list of all … Read more
The DAPA-HF trial was definitely the highlight of the scientific sessions at the AHA19 conference. I’m fascinated by the interesting outcomes and keen to learn more about the effect of SGLT-2 inhibitors on heart failure (HF) patients with preserved ejection fraction (HFpEF). In the next few lines, I’m going to briefly discuss the significant findings … Read more